Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease

C Borghi, E Agabiti-Rosei, RJ Johnson… - European journal of …, 2020 - Elsevier
During the last century, there has been an increasing prevalence of hyperuricaemia noted in
many populations. While uric acid is usually discussed in the context of gout …

Physiology of hyperuricemia and urate-lowering treatments

CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …

Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels

A Tin, J Marten, VL Halperin Kuhns, Y Li, M Wuttke… - Nature …, 2019 - nature.com
Elevated serum urate levels cause gout and correlate with cardiometabolic diseases via
poorly understood mechanisms. We performed a trans-ancestry genome-wide association …

Коморбидная патология в клинической практике. Клинические рекомендации

РГ Оганов, ИН Денисов, В Симаненков… - Кардиоваскулярная …, 2017 - cyberleninka.ru
Рабочая группа: академик РАН, профессор РГ Оганов (Председатель)(Москва),
академик РАН, профессор ИН Денисов (Председатель)(Москва), профессор ВИ …

Asymptomatic hyperuricaemia: a silent activator of the innate immune system

LAB Joosten, TO Crişan, P Bjornstad… - Nature Reviews …, 2020 - nature.com
Asymptomatic hyperuricaemia affects~ 20% of the general population in the USA, with
variable rates in other countries. Historically, asymptomatic hyperuricaemia was considered …

Uric acid and the cardio‐renal effects of SGLT2 inhibitors

CJ Bailey - Diabetes, Obesity and Metabolism, 2019 - Wiley Online Library
Sodium/glucose co‐transporter‐2 (SGLT2) inhibitors, which lower blood glucose by
increasing renal glucose elimination, have been shown to reduce the risk of adverse …

Urate, blood pressure, and cardiovascular disease: evidence from mendelian randomization and meta-analysis of clinical trials

D Gill, AC Cameron, S Burgess, X Li, DJ Doherty… - …, 2021 - Am Heart Assoc
Serum urate has been implicated in hypertension and cardiovascular disease, but it is not
known whether it is exerting a causal effect. To investigate this, we performed Mendelian …

Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials

M Bredemeier, LM Lopes, MA Eisenreich… - BMC cardiovascular …, 2018 - Springer
Background Xanthine oxidase inhibitors (XOI), classified as purine-like (allopurinol and
oxypurinol) and non-purine (febuxostat and topiroxostat) XOI, present antioxidant properties …

Asymptomatic hyperuricemia: is it really asymptomatic?

K Yip, RE Cohen, MH Pillinger - Current opinion in rheumatology, 2020 - journals.lww.com
Accumulating evidence suggests that asymptomatic hyperuricemia contributes to the
comorbidities with which it associates and that proper asymptomatic hyperuricemia …

Hyperuricemia and progression of chronic kidney disease: a review from physiology and pathogenesis to the role of urate-lowering therapy

TH Lee, JJ Chen, CY Wu, CW Yang, HY Yang - Diagnostics, 2021 - mdpi.com
The relationship between hyperuricemia, gout, and renal disease has been investigated for
several years. From the beginning, kidney disease has been considered a complication of …